Deep Brain Stimulation for Essential Tremor

DA
Overseen ByDanielle A Pietramala
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of British Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if a new programming method for Deep Brain Stimulation (DBS) using the Chronos™ DBS system can assist individuals with essential tremor (ET) who no longer benefit from standard DBS treatment. Researchers will test six different stimulation settings to identify any that improve tremor symptoms more effectively than the standard treatment. Ideal participants are adults with ET who have undergone DBS surgery but experienced a rapid decline in tremor benefits. Participants will try various DBS settings in the clinic, use one setting at home, and attend follow-up visits to monitor progress. As an unphased trial, this study provides a unique opportunity to explore innovative DBS programming for those seeking improved tremor management.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this new DBS programming method is safe for essential tremor patients?

Studies have shown that deep brain stimulation (DBS) for essential tremor is generally well-tolerated. Research on patients with essential tremor who received DBS on both sides of the brain indicates it is safe for most people. When previous DBS settings became less effective, researchers tested new stimulation patterns using a software called Chronos™.

Although specific safety data for Chronos™ is limited, the existing use of DBS for essential tremor suggests it is generally safe. Participants in earlier studies did not report any major safety concerns. However, like any medical treatment, some side effects might occur, such as mild discomfort or temporary changes in mood or thinking.

Overall, while past DBS use shows promising safety evidence, participants should discuss any concerns with their doctors.12345

Why are researchers excited about this trial?

Researchers are excited about Chronos™ DBS for essential tremor because it offers a personalized approach to deep brain stimulation. Unlike traditional DBS systems, which usually rely on fixed settings, Chronos™ allows for customizable stimulation programs tailored to an individual’s specific needs. This adaptability aims to improve tremor control while minimizing side effects, potentially offering a more efficient and effective management of symptoms compared to standard treatments like medication or conventional DBS devices.

What evidence suggests that this new DBS programming is effective for essential tremor?

Research has shown that traditional Deep Brain Stimulation (DBS) for essential tremor (ET) may become less effective over time, with a 50% improvement in tremors observed after one year. However, advanced DBS programming offers hope. In this trial, participants will test six different experimental DBS stimulation programs using Chronos™ software. These new methods change the delivery of stimulation to better control tremors. Early results suggest that different settings might help regain tremor control in patients who no longer benefit from standard DBS. This approach is being tested to determine if it can provide longer-lasting improvement for people with ET.12678

Are You a Good Fit for This Trial?

This trial is for adults with essential tremor who no longer respond to standard Deep Brain Stimulation (DBS) therapy. Only 5 participants will be included, and they must have experienced a quick loss of benefit after receiving standard VIM-DBS treatment.

Inclusion Criteria

I have essential tremor and had DBS surgery.
Demonstrated rapid (early) habituation to standard programming
Ability to provide informed consent and attend follow-up visits

Exclusion Criteria

I cannot attend the required visits for the program.
Language impairment precluding consent
I do not have any brain conditions that could affect tremor evaluations.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants complete a clinic visit to try six different DBS stimulation settings using specialized Chronos software and are randomly assigned to one setting for home use

3 months
1 clinic visit, home use

Follow-up

Participants receive a follow-up phone call at 4 weeks to check on symptoms and device use, and return to the clinic at 3 months for a full tremor evaluation

4 weeks and 3 months
1 phone call, 1 clinic visit

Optional Long-term Follow-up

Participants have the option to return for an additional follow-up visit at 1 year

1 year
1 optional clinic visit

What Are the Treatments Tested in This Trial?

Interventions

  • Chronos™ DBS

Trial Overview

The study tests new DBS programming methods using the Chronos system in patients with essential tremor. It compares six different stimulation settings to see if they can restore and maintain tremor control better than the standard approach.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Single Experimental ArmExperimental Treatment6 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of British Columbia

Lead Sponsor

Trials
1,506
Recruited
2,528,000+

Boston Scientific Corporation

Industry Sponsor

Trials
758
Recruited
867,000+
Michael F. Mahoney profile image

Michael F. Mahoney

Boston Scientific Corporation

Chief Executive Officer since 2016

MBA from Wake Forest University, BBA in Finance from the University of Iowa

Kenneth Stein profile image

Kenneth Stein

Boston Scientific Corporation

Chief Medical Officer since 2020

MD from Harvard Medical School, MMSc in Clinical Investigation from Harvard-MIT Division of Health Sciences and Technology

Citations

NCT07302867 | Neuromodulation Strategies for Treatment ...

The goal of this observational study is to learn whether a new way of programming Deep Brain Stimulation (DBS) can improve and maintain tremor ...

Deep Brain Stimulation for Tremor: Update on Long-Term ...

However, Vim-DBS efficiency reduces over time, with total tremor scores showing a 55–65% improvement at 6 months, 53–66% improvement at 12 months, 50% ...

Directional Bilateral Thalamic Patterned Stimulation ...

Objectives: The primary objective in Phase 2 is to evaluate the safety and effectiveness of bilateral VIM-DBS in individuals with essential tremor. In Phase 1, ...

Neuromodulation Strategies for Treatment-Resistant Essential ...

Researchers will compare six different stimulation settings to see if any of them can improve tremor symptoms when standard DBS programming no ...

5.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/23018417/

Long-term effects of deep brain stimulation for essential ...

Results: Twenty-six patients responded, with a median follow-up of 41 months. Approximately half of the patients had more than 48 months of follow-up. At the ...

Proceedings of the 10th annual deep brain stimulation think tank

Automated deep brain stimulation programming with safety constraints for tremor suppression in patients with Parkinson's disease and essential tremor. J ...

Neuromodulation Strategies for Treatment-Resistant Essential ...

Researchers will compare six different stimulation settings to see if any of them can improve tremor symptoms when standard DBS programming no ...

DBS Programming for Essential Tremor

Research has shown that deep brain stimulation (DBS) on both sides of the brain for essential tremor is generally well-tolerated. One study found that this ...